These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14738462)

  • 1. Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes.
    Füchtenbusch M; Bonifacio E; Lampasona V; Knopff A; Ziegler AG
    Clin Exp Immunol; 2004 Feb; 135(2):318-21. PubMed ID: 14738462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy.
    Yu SH; Park S; Kim HS; Park SY; Yim CH; Han KO; Yoon HK; Jang HC; Chung HY; Kim SH
    Diabetes Metab Res Rev; 2009 May; 25(4):329-34. PubMed ID: 19405080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes.
    Dereke J; Nilsson C; Strevens H; Landin-Olsson M; Hillman M
    Clin Immunol; 2016 Jan; 162():45-8. PubMed ID: 26548838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus.
    Papadopoulou A; Lynch KF; Anderberg E; Landin-Olsson M; Hansson I; Agardh CD; Lernmark Å; Berntorp K
    Diabetes Res Clin Pract; 2012 Feb; 95(2):260-4. PubMed ID: 22104260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M; Kredel K; Bonifacio E; Schnell O; Ziegler AG
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
    Couper JJ; Harrison LC; Aldis JJ; Colman PG; Honeyman MC; Ferrante A
    Hum Immunol; 1998 Aug; 59(8):493-9. PubMed ID: 9712353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study.
    Füchtenbusch M; Ferber K; Standl E; Ziegler AG
    Diabetes; 1997 Sep; 46(9):1459-67. PubMed ID: 9287047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese.
    Kasuga A; Shimada A; Ozawa Y; Maruyama T; Oya K; Saruta T
    Endocr J; 2000 Feb; 47(1):57-62. PubMed ID: 10811294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
    Hillman M; Törn C; Landin-Olsson M;
    Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes.
    Balsells M; Corcoy R; Mauricio D; Morales J; García-Patterson A; Carreras G; Puig-Domingo M; de Leiva A
    Diabetes Care; 1997 Jul; 20(7):1172-5. PubMed ID: 9203458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glutamic Acid Decarboxylase Antibody-Positive Gestational Diabetes Mellitus with Autoimmune Type 1 Diabetes Mellitus in the Early Postpartum Period: A Case Report and Literature Review.
    Fujishima A; Onodera Y; Miura H; Terada Y
    Tohoku J Exp Med; 2023 Apr; 259(4):327-333. PubMed ID: 36823183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.